Effect of collaborative dementia care on potentially inappropriate medication use: Outcomes from the Care Ecosystem randomized clinical trial
暂无分享,去创建一个
S. Bonasera | Kirby P. Lee | W. Chiong | J. Merrilees | K. M. Cook | K. Possin | S. Lynch | Tamara L. Braley | Amy M. Clark | Sarah Dulaney | Bruce L. Miller | Rachel E Kiekhofer | Julie E Feuer | I. Allen | E. Guterman | Rosalie Gearhart | Amy K. Liu | Joan Ewalt
[1] C. Boyd,et al. Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care Clinicians , 2022, JAMA internal medicine.
[2] N. Herrmann,et al. CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia , 2022, Alzheimer's & dementia.
[3] K. Yaffe,et al. Polypharmacy among older adults with dementia compared with those without dementia in the United States , 2021, Journal of the American Geriatrics Society.
[4] K. Langa,et al. Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US. , 2021, JAMA.
[5] M. Kuzuya,et al. Use of Anti-Dementia Drugs Reduces the Risk of Potentially Inappropriate Medications: A Secondary Analysis of a Nationwide Survey of Prescribing Pharmacies , 2020, Dementia and Geriatric Cognitive Disorders.
[6] D. Melzer,et al. Potentially inappropriate prescribing in dementia, multi-morbidity and incidence of adverse health outcomes. , 2020, Age and ageing.
[7] T. Wilt,et al. Care Interventions for People Living With Dementia and Their Caregivers , 2020 .
[8] Naaheed Mukadam,et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission , 2020, The Lancet.
[9] L. Flicker,et al. Optimisation of medications used in residential aged care facilities: a systematic review and meta-analysis of randomised controlled trials , 2020, BMC Geriatrics.
[10] B. Lawlor,et al. Potentially inappropriate medication use in older adults with mild-moderate Alzheimer's disease: prevalence and associations with adverse events. , 2020, Age and ageing.
[11] Amy E. Sanders,et al. Quality Improvement in Dementia Care: Dementia Management Quality Measurement Set 2018 Implementation Update. , 2020, The American journal of psychiatry.
[12] Y. Loke,et al. Interventions to Reduce Anticholinergic Burden in Adults Aged 65 and Older: A Systematic Review. , 2020, Journal of the American Medical Directors Association.
[13] L. Clare,et al. Potentially inappropriate prescribing in dementia: a state-of-the-art review since 2007 , 2020, BMJ Open.
[14] J. Schnipper,et al. A systematic overview of systematic reviews evaluating interventions addressing polypharmacy. , 2019, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[15] S. Bonasera,et al. Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized Clinical Trial. , 2019, JAMA internal medicine.
[16] S. Bonasera,et al. The Role of Care Navigators Working with People with Dementia and Their Caregivers. , 2019, Journal of Alzheimer's disease : JAD.
[17] S. Bonasera,et al. Variations in Costs of a Collaborative Care Model for Dementia , 2019, Journal of the American Geriatrics Society.
[18] J. Hanlon,et al. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults , 2019, Journal of the American Geriatrics Society.
[19] U. Macleod,et al. Identifying potentially inappropriate prescribing in older people with dementia: a systematic review , 2019, European Journal of Clinical Pharmacology.
[20] Robyn Tamblyn,et al. Effect of a Pharmacist-Led Educational Intervention on Inappropriate Medication Prescriptions in Older Adults: The D-PRESCRIBE Randomized Clinical Trial , 2018, JAMA.
[21] D. Gerritsen,et al. The effect of biannual medication reviews on the appropriateness of psychotropic drug use for neuropsychiatric symptoms in patients with dementia: a randomised controlled trial , 2018, Age and ageing.
[22] M. Boustani,et al. Ongoing Medical Management to Maximize Health and Well-being for Persons Living With Dementia , 2018, The Gerontologist.
[23] Stefan Teipel,et al. Effectiveness and Safety of Dementia Care Management in Primary Care: A Randomized Clinical Trial , 2017, JAMA psychiatry.
[24] G. Jicha,et al. Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden , 2017, Alzheimer's Research & Therapy.
[25] Linda Lee,et al. Use of potentially inappropriate medications among ambulatory home-dwelling elderly patients with dementia: A review of the literature , 2017, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.
[26] C. Parsons. Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem , 2017, Therapeutic advances in drug safety.
[27] J. Galvin. The Quick Dementia Rating System (QDRS): A rapid dementia staging tool , 2015, Alzheimer's & dementia.
[28] L. Schneider,et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. , 2015, JAMA psychiatry.
[29] Sascha Dublin,et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. , 2015, JAMA internal medicine.
[30] S. Yusuf,et al. The burden of disease in older people and implications for health policy and practice , 2015, The Lancet.
[31] L. Thabane,et al. Empirical comparison of four baseline covariate adjustment methods in analysis of continuous outcomes in randomized controlled trials , 2014, Clinical epidemiology.
[32] Antoni Sicras-Mainar,et al. Comorbidity of dementia: a cross-sectional study of primary care older patients , 2014, BMC Psychiatry.
[33] Ann M. Philbrick,et al. Medication reconciliation by clinical pharmacists in an outpatient family medicine clinic. , 2014, Journal of the American Pharmacists Association : JAPhA.
[34] Amy E. Sanders,et al. Quality Improvement in Neurology: Dementia Management Quality Measures (Executive Summary) , 2013, The American journal of occupational therapy : official publication of the American Occupational Therapy Association.
[35] S. Simon,et al. Medication discrepancies in integrated electronic health records , 2012, BMJ quality & safety.
[36] T. Furukawa,et al. How to Obtain NNT from Cohen's d: Comparison of Two Methods , 2011, PloS one.
[37] M. Boustani,et al. Impact of anticholinergics on the aging brain: a review and practical application , 2008 .
[38] D. Meltzer,et al. Use of a Self-Report-Generated Charlson Comorbidity Index for Predicting Mortality , 2005, Medical care.
[39] D. Altman,et al. Analysing controlled trials with baseline and follow up measurements , 2001, BMJ : British Medical Journal.
[40] M. Kelly,et al. Medication discrepancies in an outpatient electronic medical record. , 2001, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[41] Michael H. Connors,et al. Potentially Inappropriate Medication, Anticholinergic Burden, and Mortality in People Attending Memory Clinics. , 2017, Journal of Alzheimer's disease : JAD.
[42] C. Hughes,et al. Potentially Inappropriate Prescribing Among People with Dementia in Primary Care: A Retrospective Cross-Sectional Study Using the Enhanced Prescribing Database. , 2016, Journal of Alzheimer's disease : JAD.
[43] C. Steiner,et al. Comorbidity measures for use with administrative data. , 1998, Medical care.
[44] R. Little. A Test of Missing Completely at Random for Multivariate Data with Missing Values , 1988 .